<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: DNA aberrations that cause <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) occur in multiple steps that involve microsatellite instability (MSI) and <z:mp ids='MP_0008866'>chromosomal instability</z:mp> (CIN) </plain></SENT>
<SENT sid="1" pm="."><plain>Herein, we studied <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> from AA patients for their CIN and MSI status </plain></SENT>
<SENT sid="2" pm="."><plain>EXPERIMENTAL DESIGN: Array CGH was performed on 30 AA <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The MSI status was established </plain></SENT>
<SENT sid="4" pm="."><plain>The CGH data from AA were compared to published lists of 41 TSG and oncogenes in Caucasians and 68 cancer genes, proposed via systematic sequencing for <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in colon and <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">breast tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The patient-by-patient CGH profiles were organized into a maximum parsimony cladogram to give insights into the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>' aberrations lineage </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The CGH analysis revealed that CIN was independent of age, gender, stage or location </plain></SENT>
<SENT sid="7" pm="."><plain>However, both the number and nature of aberrations seem to depend on the MSI status </plain></SENT>
<SENT sid="8" pm="."><plain>MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> clustered together in the cladogram </plain></SENT>
<SENT sid="9" pm="."><plain>The chromosomes with the highest rates of CGH aberrations were 3, 5, 7, 8, 20 and X </plain></SENT>
<SENT sid="10" pm="."><plain>Chromosome X was primarily amplified in male patients </plain></SENT>
<SENT sid="11" pm="."><plain>A comparison with Caucasians revealed an overall similar aberration profile with few exceptions for the following genes; THRB, RAF1, LPL, <z:chebi fb="8" ids="53090">DCC</z:chebi>, XIST, PCNT, STS and genes on the 20q12-q13 cytoband </plain></SENT>
<SENT sid="12" pm="."><plain>Among the 68 CAN genes, <z:hpo ids='HP_0000001'>all</z:hpo> showed some level of alteration in our cohort </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: Chromosome X amplification in male patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> merits follow-up </plain></SENT>
<SENT sid="14" pm="."><plain>The observed CIN may play a distinctive role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in AAs </plain></SENT>
<SENT sid="15" pm="."><plain>The clustering of MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in global CGH data analysis suggests that chromosomal aberrations are not random </plain></SENT>
</text></document>